NEW YORK ( TheStreet) -- CHANGE IN RATINGS:
was downgraded at Goldman Sachs from buy to neutral. Valuation call, as the stock is up more than 33% since late December, Goldman said. $21 price target.
was downgraded at Oppenheimer to perform from outperform. Market has recognized turnaround, Oppenheimer said.
Associated Banc-Corp was upgraded at Morgan Stanley to equal-weight. $14 price target. Management is turning the business around, Morgan Stanley said.
(AVB - Get Report)
was downgraded at Jefferies to hold from buy. $135 price target. 2013 outlook disappointment, Jefferies said.
was upgraded at Barclays from equal-weight to overweight. $64 price target. Company will continue to benefit from a housing shortage, Barclays said.
Bed Bath & Beyond
(BBBY - Get Report)
was upgraded at Citigroup to buy from neutral. $67 price target. Compelling valuation and improving differentiation, Citigroup said.
(BBT - Get Report)
was upgraded at Guggenheim from neutral to buy. $38 price target. Company will likely raise its dividend in the near term, Guggenheim said.
was downgraded at Stifel Nicolaus from buy to hold. Company is spending more to invest in online video and mobile internet, Stifel said.
Bank of NY Mellon
was downgraded at Guggenheim from buy to neutral. Valuation call, based on a $28 price target, Guggenheim said.
was upgraded at Oppenheimer to outperform from perform. $68 price target. Loan growth is beginning to accelerate, Oppenheimer said.
was downgraded at Nomura from buy to neutral. $45 price target. Valuation call, as the stock is up 16% over the past two months, Nomura said.
was downgraded at DA Davidson from neutral to underperform. DISH deal will likely not go through, DA Davidson said. $2.97 price target.
was upgraded at Barclays from equal-weight to overweight. $27 price target. Expect better credit availability to drive demand for entry-level homes, Barclays said.
was downgraded at Craig-Hallum from buy to hold. Valuation call, based on a $29 price target, Craig-Hallum said.
was downgraded at Jefferies to hold from buy. $58 price target. Negative read-through from AVB results, Jefferies said.